| David Luigi Manzo, MD | |
|
621 W 11 Mile Rd, Royal Oak, MI 48067-2201 | |
| (248) 541-4200 | |
| (248) 541-4969 |
| Full Name | David Luigi Manzo |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 40 Years |
| Location | 621 W 11 Mile Rd, Royal Oak, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386648103 | NPI | - | NPPES |
| 4113369 | Other | MI | AETNA |
| 4229975 TYPE 10 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | DM048656 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Michigan Eye Care Provider Pllc | 1254611809 | 15 |
News Archive
Inspire Pharmaceuticals, Inc. announced today the results from two Phase 2 clinical trials with AZASITE (azithromycin ophthalmic solution) 1% for the treatment of blepharitis. Inspire will conduct additional clinical work to continue pursuing a potential indication for treatment of anterior and posterior forms of blepharitis.
According to the Alzheimer's Association "Hispanic Perceptions of Alzheimer's Disease" survey, which was funded by MetLife Foundation and released today during National Hispanic Heritage Month, 64 percent of survey respondents felt that the Latino community is not very aware or not at all aware of Alzheimer's disease.
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has contracted with BioE, St. Paul, Minnesota, to provide the newest "state of the art" cord blood processing systems for its Las Vegas operations.
For the first time, a strategic plan for research into benign prostate disease, based on the latest scientific knowledge, has been published by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH). The NIDDK Prostate Research Strategic Plan is the culmination of discussions and meetings among experts over the past two years in an effort to outline a strategic vision for research into these elusive and multi-faceted diseases.
› Verified 4 days ago
| Entity Name | Michigan Eye Care Provider Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598151318 PECOS PAC ID: 1254611809 Enrollment ID: O20161216002192 |
News Archive
Inspire Pharmaceuticals, Inc. announced today the results from two Phase 2 clinical trials with AZASITE (azithromycin ophthalmic solution) 1% for the treatment of blepharitis. Inspire will conduct additional clinical work to continue pursuing a potential indication for treatment of anterior and posterior forms of blepharitis.
According to the Alzheimer's Association "Hispanic Perceptions of Alzheimer's Disease" survey, which was funded by MetLife Foundation and released today during National Hispanic Heritage Month, 64 percent of survey respondents felt that the Latino community is not very aware or not at all aware of Alzheimer's disease.
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has contracted with BioE, St. Paul, Minnesota, to provide the newest "state of the art" cord blood processing systems for its Las Vegas operations.
For the first time, a strategic plan for research into benign prostate disease, based on the latest scientific knowledge, has been published by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH). The NIDDK Prostate Research Strategic Plan is the culmination of discussions and meetings among experts over the past two years in an effort to outline a strategic vision for research into these elusive and multi-faceted diseases.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Luigi Manzo, MD 621 W 11 Mile Rd, Royal Oak, MI 48067-2201 Ph: (248) 541-4200 | David Luigi Manzo, MD 621 W 11 Mile Rd, Royal Oak, MI 48067-2201 Ph: (248) 541-4200 |
News Archive
Inspire Pharmaceuticals, Inc. announced today the results from two Phase 2 clinical trials with AZASITE (azithromycin ophthalmic solution) 1% for the treatment of blepharitis. Inspire will conduct additional clinical work to continue pursuing a potential indication for treatment of anterior and posterior forms of blepharitis.
According to the Alzheimer's Association "Hispanic Perceptions of Alzheimer's Disease" survey, which was funded by MetLife Foundation and released today during National Hispanic Heritage Month, 64 percent of survey respondents felt that the Latino community is not very aware or not at all aware of Alzheimer's disease.
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has contracted with BioE, St. Paul, Minnesota, to provide the newest "state of the art" cord blood processing systems for its Las Vegas operations.
For the first time, a strategic plan for research into benign prostate disease, based on the latest scientific knowledge, has been published by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH). The NIDDK Prostate Research Strategic Plan is the culmination of discussions and meetings among experts over the past two years in an effort to outline a strategic vision for research into these elusive and multi-faceted diseases.
› Verified 4 days ago
Tedi Begaj, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3555 W 13 Mile Rd Ste Ll-20, Royal Oak, MI 48073 Phone: 248-288-2280 | |
Dr. Robert J Mcdonald, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 32000 Woodward Ave, Royal Oak, MI 48073 Phone: 248-549-6000 Fax: 248-549-4923 | |
Huiyan Jin, Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3535 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-551-3643 | |
Dr. Sahal H. Saleh, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-551-3000 | |
Dr. George R Lesser, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3535 W 13 Mile Rd, Suite 645, Royal Oak, MI 48073 Phone: 248-220-5252 Fax: 248-220-5261 | |
Dr. Tarek Shawky Hassan, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3555 W 13 Mile Rd, Ll-20, Royal Oak, MI 48073 Phone: 248-288-2280 Fax: 248-288-5644 | |
Dr. Safa Arfeen, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd Ofc, Royal Oak, MI 48073 Phone: 248-551-6347 |